BMC Pulmonary Medicine
Scope & Guideline
Empowering innovation in pulmonary medicine for a healthier tomorrow.
Introduction
Aims and Scopes
- Pulmonary Disease Research:
The journal covers a wide range of pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, and pulmonary hypertension, emphasizing both clinical and translational research. - Innovative Diagnostic Techniques:
Research focusing on novel diagnostic approaches such as imaging techniques (e.g., CT and MRI), biomarkers, and endobronchial ultrasound is prevalent, promoting advancements in early detection and monitoring of lung diseases. - Therapeutic Interventions:
The journal publishes studies on various treatment modalities including pharmacological interventions, surgical approaches, and emerging therapies such as biologics and immunotherapy, aiming to improve patient outcomes. - Public Health and Epidemiology:
There is a strong emphasis on epidemiological studies that investigate the prevalence, risk factors, and socio-economic impacts of respiratory diseases, particularly in diverse populations. - Patient-Centered Outcomes:
Research evaluating health-related quality of life, patient experiences, and adherence to treatment regimens is prioritized, reflecting a commitment to improving patient care in pulmonary medicine. - Mechanistic and Pathophysiological Studies:
The journal includes studies that explore the underlying mechanisms of pulmonary diseases, including genetic, molecular, and cellular factors contributing to disease progression.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telehealth strategies in pulmonary care, with increasing research on the effectiveness of remote monitoring and virtual rehabilitation programs for managing chronic respiratory diseases. - Personalized Medicine and Biomarkers:
There is a growing focus on personalized approaches in treatment, including the use of biomarkers for tailoring therapies in conditions like asthma and idiopathic pulmonary fibrosis, reflecting advancements in precision medicine. - Impact of Environmental Factors:
Research increasingly addresses the effects of air pollution, occupational exposures, and climate change on respiratory health, emphasizing the need for public health interventions and policy changes. - Machine Learning and Artificial Intelligence:
The integration of machine learning and AI in diagnostic and prognostic models for lung diseases is emerging as a key area of research, enhancing predictive accuracy and patient outcomes. - Multimorbidity in Pulmonary Diseases:
An increasing number of studies are addressing the intersection of pulmonary diseases with other chronic conditions, focusing on comprehensive management strategies that consider the whole patient. - Health Disparities and Access to Care:
Research investigating health disparities in respiratory diseases, particularly among underserved populations, is gaining attention, highlighting the need for equitable healthcare access.
Declining or Waning
- Traditional Smoking Cessation Studies:
Research solely focused on methods for smoking cessation has declined, as the journal shifts toward integrated approaches that consider smoking as part of a broader spectrum of pulmonary disease management. - Single-Disease Focus:
There is a noticeable reduction in studies exclusively targeting individual diseases without considering comorbidities, as the journal increasingly emphasizes the interconnectedness of various respiratory conditions. - Basic Science without Clinical Relevance:
The journal appears to be moving away from purely basic science studies that do not have direct clinical implications, prioritizing translational research that impacts patient care. - Outdated Therapeutic Approaches:
Research centered on older therapeutic modalities without new insights or comparative effectiveness has diminished, reflecting a trend towards innovative and evidence-based treatment strategies.
Similar Journals
THORAX
Advancing pulmonary knowledge, one study at a time.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
CHEST
Transforming critical care through innovative studies.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Enhancing clinical outcomes through impactful research.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
RESPIRATORY RESEARCH
Empowering Collaboration in Pulmonary ResearchRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
Annals of Thoracic Medicine
Fostering collaboration in the pursuit of thoracic excellence.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
RESPIRATORY MEDICINE
Unraveling Complexities of Respiratory ConditionsRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
Chronic Respiratory Disease
Connecting researchers to enhance respiratory outcomes.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
BMJ Open Respiratory Research
Shaping the future of respiratory care with open access insights.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
RESPIRATION
Elevating Knowledge in Respiratory HealthRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Therapeutic Advances in Respiratory Disease
Unlocking Insights for Enhanced Patient OutcomesTherapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.